Trial intelligence / Profile preview

Influenza vaccine immune response in obese versus non-obese children and adolescents

ACTRN12617001086358Phase 4Completed

Sponsor
Women's and Children's Hospital
Start
Jul 2019
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4, open-label trial of quadrivalent influenza vaccine in influenza (2 arms), sponsored by Women's and Children's Hospital. Primary endpoints: Seroprotective HIA titre proportion and Four-fold rise in HIA titres. Started Jul 2019; status: completed.

02

Drugs

quadrivalent influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on ACTRN12617001086358.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12617001086358.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call